BIOXXMED AG INH O.N./ DE000A0KFRJ1 /
2024-03-28 5:36:06 PM | Chg. +0.072 | Volume | Bid2024-03-28 | Ask2024-03-28 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.374EUR | +23.84% | 3,000 Turnover: 1,116 |
-Bid Size: - | -Ask Size: - | 1.51 mill.EUR | 0.00% | - |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -1.01 EUR | 120.70% |
EPS Diluted: | -1.01 EUR | 120.70% |
Revenues per Share: | 0.01 EUR | 0.00% |
Book Value per Share: | 4.44 EUR | -18.26% |
Cash Flow per Share: | - EUR | - |
Dividend per Share: | 0.00 EUR | - |
Total | in mill. | |
Revenues: | 0.04 EUR | 0.00% |
Net Income: | -4.10 EUR | 127.78% |
Operating Cash Flow: | - EUR | - |
Cash and Cash Equivalents: | 0.00 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 37.66 | 475.30 |
P/BV ratio: | 0.08 | 1.06 |
P/CF Ratio: | - | - |
PEG: | 0.00 | - |
Earnings Yield: | -269.44% | -21.35% |
Dividend Yield: | 0.00% | 0.00% |
Market Capitalization | ||
Market Capitalization: | 1.51 mill. EUR | 19.01 mill. EUR |
Free Float Market Cap.: | 798,429.9618 EUR | 10.08 mill. EUR |
Market Cap. / Employee: | 1.51 mill. EUR | 19.01 mill. EUR |
Shares Outstanding: | 4.03 mill. |
Profitability
Gross Profit Margin: | -1,150.00% |
EBIT Margin: | -10,000.00% |
Net Profit Margin: | -10,250.00% |
Return on Equity: | -22.91% |
Return on Assets: | -22.40% |
Financial Strength
Liquidity I / Cash Ratio: | - |
Liquidity II / Quick Ratio: | - |
Liquidity III / Current Ratio: | - |
Debt / Equity Ratio: | 2.23% |
Dynam. Debt / Equity Ratio: | - |
Efficiency
Employees: | 1 |
Personal Expenses / Employee: | 500,000.00 EUR |
Revenues / Employee: | 40,000.00 EUR |
Net Income / Employee: | -4,100,000.00 EUR |
Total Assets / Employee: | 18,300,000.00 EUR |
* Fiscal Year End: | 2021-12-31 |
Accounting Standard: | HGB |
Currency: | EUR |